Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis
- PMID: 38037191
- PMCID: PMC11219471
- DOI: 10.1093/ibd/izad288
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis
Abstract
Background: Patients with ulcerative colitis and total abdominal proctocolectomy with ileal pouch-anal anastomosis have a 50% risk of pouchitis and a 5% to 10% risk of chronic pouchitis.
Aims: The goal of the study was to compare pouch microbiota and stool bile acid composition in patients with chronic pouchitis, chronic pouchitis and primary sclerosing cholangitis, and normal pouch.
Methods: Patients with ulcerative colitis and ileal pouch-anal anastomosis were recruited from March 20, 2014, to August 6, 2019, and categorized into normal pouch, chronic pouchitis, and chronic pouchitis/primary sclerosing cholangitis groups. Stool samples were subjected to bile acid quantification and 16S rRNA gene sequencing. Statistical comparisons of absolute bile acid abundance and pouch microbiota α-diversity, β-diversity, and taxa abundance were performed among the patient groups.
Results: A total of 51 samples were analyzed. Both α-diversity (P = .01, species richness) and β-diversity (P = .001) significantly differed among groups. Lithocholic acid was significantly lower in patients with chronic pouchitis/primary sclerosing cholangitis than in those with chronic pouchitis (P = .01) or normal pouch (P = .03). Decreased α-diversity was associated with an increased primary to secondary bile acid ratio (P = .002), which was also associated with changes in β-diversity (P = .006).
Conclusions: Pouch microbiota α- and β-diversity differed among patients with normal pouch, chronic pouchitis, and chronic pouchitis/primary sclerosing cholangitis. Lithocholic acid level and primary to secondary bile acid ratio were highly associated with pouch microbiota richness, structure, and composition. These findings emphasize the associations between pouch microbiota and bile acid composition in dysbiosis and altered metabolism, suggesting that secondary bile acids are decreased in chronic pouchitis.
Keywords: inflammatory bowel disease; microbiome; pouchitis; primary sclerosing cholangitis; ulcerative colitis.
Plain language summary
The α- and β-diversity of the pouch microbiota significantly differed in chronic pouchitis, chronic pouchitis and primary sclerosing cholangitis, and normal pouch. Microbiota changes were associated with stool bile acid composition. Decreased diversity was associated with decreased secondary bile acids.
© The Author(s) 2023. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
L.R., Janssen Pharmaceuticals—Advisory board
Figures





Comment in
-
Altered Bile Acids and Pouch Microbiota Composition in Patients With Chronic Pouchitis.Inflamm Bowel Dis. 2025 Apr 10;31(4):1184-1187. doi: 10.1093/ibd/izaf005. Inflamm Bowel Dis. 2025. PMID: 40073325
Similar articles
-
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.World J Gastroenterol. 2014 Aug 7;20(29):9665-74. doi: 10.3748/wjg.v20.i29.9665. World J Gastroenterol. 2014. PMID: 25110406 Free PMC article.
-
Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis.Tech Coloproctol. 2024 Aug 21;28(1):113. doi: 10.1007/s10151-024-02976-6. Tech Coloproctol. 2024. PMID: 39167239
-
Prevalence and predictability of the Chicago Classification of Pouchitis in ulcerative colitis: a multicenter study in Japan.J Gastroenterol. 2025 Jun;60(6):715-726. doi: 10.1007/s00535-025-02231-1. Epub 2025 Mar 6. J Gastroenterol. 2025. PMID: 40050487 Free PMC article.
-
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease.Inflamm Bowel Dis. 2025 Jan 6;31(1):63-71. doi: 10.1093/ibd/izae106. Inflamm Bowel Dis. 2025. PMID: 38916136 Free PMC article.
-
Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.Dig Dis Sci. 2022 Jun;67(6):1948-1955. doi: 10.1007/s10620-021-07002-5. Epub 2021 Jun 7. Dig Dis Sci. 2022. PMID: 34097166
Cited by
-
Optimal Approaches to Treating and Preventing Acute and Chronic Pouchitis by Altering Microbial Profiles.Gastroenterol Clin North Am. 2025 Jun;54(2):469-483. doi: 10.1016/j.gtc.2024.12.007. Epub 2025 Jan 9. Gastroenterol Clin North Am. 2025. PMID: 40348499 Review.
-
Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Acute Pouchitis: A Matched Cohort Study from the United States.Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09039-2. Online ahead of print. Dig Dis Sci. 2025. PMID: 40237906
-
Cellular and molecular mechanisms in the pathogenesis of pouchitis: more than just the microbiota.Gut. 2025 Apr 16:gutjnl-2024-334445. doi: 10.1136/gutjnl-2024-334445. Online ahead of print. Gut. 2025. PMID: 40240062 Free PMC article. Review.
-
Gut microbiota in liver diseases: initiation, development and therapy.Front Med (Lausanne). 2025 Jun 4;12:1615839. doi: 10.3389/fmed.2025.1615839. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40534699 Free PMC article. Review.
-
Pouchitis unveiled: exploring clinical features, diagnosis, and cutting-edge treatments.Therap Adv Gastroenterol. 2025 Jan 27;18:17562848251316412. doi: 10.1177/17562848251316412. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 39877662 Free PMC article. Review.
References
-
- Quinn KP, Lightner AL, Faubion WA, Raffals LE.. A comprehensive approach to pouch disorders. Inflamm Bowel Dis. 2019;25(3):460-471. - PubMed
-
- Quinn KP, Urquhart SA, Janssens LP, et al.Primary sclerosing cholangitis-associated pouchitis: a distinct clinical phenotype. Clin Gastroenterol Hepatol. 2022;20(5):e964-e973. - PubMed
-
- Shen B. Acute and chronic pouchitis--pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol. 2012;9(6):323-333. - PubMed
-
- Reshef L, Kovacs A, Ofer A, et al.Pouch inflammation is associated with a decrease in specific bacterial taxa. Gastroenterology. 2015;149(3):718-727. - PubMed
-
- Dubinsky V, Reshef L, Bar N, et al.Predominantly antibiotic-resistant intestinal microbiome persists in patients with pouchitis who respond to antibiotic therapy. Gastroenterology. 2020;158(3):610-624.e13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical